AngioDynamics | ANGO - Le Bénéfice D'Exploitation





Le Bénéfice D'Exploitation Changement Date
Accuray USD 4.71M 6.86M 2024-12
AngioDynamics USD -2.51M 5.41M 2025-09
Artivion USD 4.79M 6.85M 2025-12
AtriCure USD 2.49M 2.28M 2025-12
Boston Scientific USD 1.24B 203M 2025-12
Edwards Lifesciences USD 370.3M 54.8M 2025-12
ICU Medical USD 26.09M 770K 2025-12
Inogen USD -7.79M 728K 2024-09
J&J USD 5.59B 1.81B 2025-12
Medtronic USD 1.74B 40M 2025-12
Merit Medical Systems USD 54.2M 11.58M 2025-12
Mesa Laboratories USD 5.78M 2.27M 2024-12
Orthofix International USD 6.12M 1.91M 2025-12
Smiths GBP 166M 76M 2026-06
Surmodics USD -5.64M 276K 2024-09
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Teleflex USD 36.34M 445.24M 2025-12
Terumo JPY 43.88B 1.21B 2025-12
Trinity Biotech USD -509K 6.27M 2025-09